JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FRANKLIN, K. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by FRANKLIN, K. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 26, Issue 3, 227-232, 1925
Copyright © 1925 by American Society for Pharmacology and Experimental Therapeutics


THE ACTION OF URETHANE ON INVOLUNTARY MUSCLE

K. J. FRANKLIN 1

1 From the Pharmacological Laboratory, Oxford

Urethane in doses between 1:45 and 1:200 has caused diminution in tone and in rhythmic movements in involuntary muscle, as studied in isolated tissue preparations. In the rabbit it has had effect on the mesenteric vein, intrapulmonary bronchus, pulmonary artery, inferior vena cava, uterus, spleen, and small intestine. In the ox it has relaxed the mesenteric vein. It has had no effect on the systemic aorta or gall-bladder of the rabbit. It has relaxed the mesenteric artery and intrapulmonary bronchus in the sheep. The action of drugs which normally cause contraction of some of the muscular tissues used is lessened or abolished. This general depressant action on isolated smooth muscle preparations makes more interesting the lack of action of urethane on the systemic blood pressure, which was first pointed out by Schmiedeberg (3) in 1885.

Submitted on March 31, 1925







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1925 by the American Society for Pharmacology and Experimental Therapeutics.